Eli Lilly | LLY - Market Capitalization

Stock Price
1,043.57
Daily Change
6.42 0.62%
Monthly
0.20%
Yearly
28.77%
Q1 Forecast
1,005.21

Eli Lilly reported $1T in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 409.03B 81.15B Sep/2025
Abbott USD 217.86B 15.25B Dec/2025
ALKERMES USD 4.95B 235M Sep/2025
Amgen USD 151.93B 1.79B Sep/2025
AstraZeneca USD 233.07B 17.56B Sep/2025
Baxter International USD 11.7B 3.84B Sep/2025
Biogen USD 20.54B 2.13B Sep/2025
Bristol-Myers Squibb USD 91.8B 2.4B Sep/2025
Drreddys Laboratories INR 2.28B 9.41B Feb/2026
Eli Lilly USD 722.15B 16.64B Sep/2025
Gilead Sciences USD 137.73B 184M Sep/2025
GlaxoSmithKline GBP 64.04B 7.8B Sep/2025
Glaxosmithkline GBP 106.96B 20.08B Feb/2026
J&J USD 500.24B 67.44B Dec/2025
Medtronic USD 120.14B 1.06B Sep/2025
Merck USD 209.64B 10.87B Sep/2025
Neurocrine Biosciences USD 13.92B 1.48B Sep/2025
Novartis USD 265.66B 9.48B Sep/2025
Novartis USD 303.91B 57.84B Feb/2026
Novo Nordisk A/S DKK 1.54T 423.96B Sep/2025
Perrigo USD 2.95B 698M Sep/2025
Pfizer USD 135.09B 2.44B Sep/2025
Prestige Brands USD 3.07B 860M Sep/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Sanofi EUR 118.94B 1.6B Feb/2026
United Therapeutics USD 18.96B 6B Sep/2025
Zoetis USD 64.85B 4.58B Sep/2025